tradingkey.logo
tradingkey.logo
Suchen

Biomerica Inc

BMRA
Zur Watchlist hinzufügen
1.750USD
-0.020-1.13%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
5.16MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Biomerica Inc Unternehmen

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Biomerica Inc Informationen

BörsenkürzelBMRA
Name des UnternehmensBiomerica Inc
IPO-datumMar 17, 1980
CEOIrani (Zackary S)
Anzahl der mitarbeiter53
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse17571 Von Karman Avenue
StadtIRVINE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92614
Telefon19493792875
Websitehttps://biomerica.com/
BörsenkürzelBMRA
IPO-datumMar 17, 1980
CEOIrani (Zackary S)

Führungskräfte von Biomerica Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Biomerica Inc?

Die fünf größten Anteilseigner von Biomerica Inc sind: Mr. Zackary S. Irani

Wie viele Institutionen halten Anteile an Biomerica Inc (BMRA)?

Mit Stand vom 2026Q1 halten 59 Institutionen Anteile an Biomerica Inc, mit einem Gesamtmarktwert von etwa 94.38K, was 3.05% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -250592.00 gestiegen.

Was ist die größte Einnahmequelle von Biomerica Inc?

Am 2026Q1 erzielte das Geschäft mit Clinical Lab für Biomerica Inc den höchsten Umsatz in Höhe von 676.00K, was 55.87% des Gesamtumsatzes entspricht.